| |
| |
|
| Insider
Information: |
Palombella Vito J. |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
868 |
|
|
Indirect Shares
|
6,741 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,609 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -125.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Infinity Pharmaceuticals Inc |
INFI |
Chief Scientific Officer |
2015-06-15 |
868 |
2015-06-15 |
6,741 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
Chief Scientific Officer |
2023-09-08 |
0 |
2020-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SURF |
Surface Oncology, Inc. |
Chief Scientific Officer |
• – – |
2023-09-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(87,212) |
0 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Chief Scientific Officer |
• – – |
2022-08-03 |
4 |
S |
$1.72 |
$7,676 |
D/D |
(4,463) |
87,212 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,000 |
91,675 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Chief Scientific Officer |
• – – |
2021-07-21 |
4 |
S |
$6.10 |
$160,583 |
D/D |
(26,325) |
53,675 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Chief Scientific Officer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
80,000 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-06-15 |
4 |
S |
$10.97 |
$51,965 |
D/D |
(4,737) |
868 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-04-30 |
4 |
OE |
$2.04 |
$9,663 |
D/D |
4,737 |
5,605 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-12-15 |
4 |
AS |
$16.32 |
$77,294 |
D/D |
(4,737) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-12-15 |
4 |
OE |
$2.04 |
$9,663 |
D/D |
4,737 |
4,737 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-11-26 |
4 |
AS |
$15.00 |
$71,040 |
D/D |
(4,736) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-11-26 |
4 |
OE |
$2.04 |
$9,661 |
D/D |
4,736 |
4,736 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-09-03 |
4 |
AS |
$15.39 |
$145,774 |
D/D |
(9,472) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-09-03 |
4 |
OE |
$2.04 |
$19,323 |
D/D |
9,472 |
9,472 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-07-01 |
4 |
AS |
$12.87 |
$11,313 |
D/D |
(879) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-06-30 |
4 |
A |
$10.83 |
$9,520 |
D/D |
879 |
879 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-02-25 |
4 |
AS |
$15.00 |
$71,040 |
D/D |
(4,736) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-02-25 |
4 |
OE |
$2.04 |
$9,661 |
D/D |
4,736 |
4,736 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-01-02 |
4 |
AS |
$13.52 |
$10,181 |
D/D |
(753) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-12-31 |
4 |
A |
$11.74 |
$8,840 |
D/D |
753 |
753 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-09-27 |
4 |
OE |
$2.04 |
$9,661 |
D/D |
4,736 |
4,736 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-09-27 |
4 |
AS |
$17.28 |
$81,837 |
D/D |
(4,736) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-06-20 |
4 |
AS |
$18.53 |
$429,067 |
D/D |
(23,150) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-06-20 |
4 |
OE |
$1.72 |
$38,017 |
D/D |
22,103 |
23,150 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific OfficerOffice |
• – – |
2010-05-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
4,117 |
|
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific OfficerOffice |
• – – |
2010-05-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,047 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
